Document 0670 DOCN M94A0670 TI Length of phases of HIV disease defined by CD4 lymphocyte count. DT 9412 AU Carlin JB; Clinical Epidemiology & Biostatistics Unit, Royal Children's; Hospital, Melbourne. SO Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:47 (abstract no. SE3). Unique Identifier : AIDSLINE ASHM5/94348985 AB OBJECTIVES: To review and synthesize available knowledge on the usual lengths of time spent by persons with HIV in each of the clinically defined phases: (1) CD4 count > 500 (x 10(6)/l), (2) CD4 count 200-500, (3) CD4 count < 200 but no AIDS-defining illness, (4) AIDS. METHODS: Extensive literature review performed of all papers reporting relevant data or statistical modelling. Estimates of phase length were derived from published models both mathematically and using computer simulations. RESULTS: Few researchers have studied the natural history of HIV disease in a way that allows estimates of the length of phases defined by CD4-count, because of the difficulty of performing necessary cohort studies and the natural variability of lymphocyte counts. From three independent studies, estimates ranging between: (1) 4.1 to 8.2 years, (2) 3.9 to 5.2 years and (3) 1.6 to 2.6 years were derived for the mean duration of the first three phases. Variances are large, especially for the first phase. CONCLUSIONS: The summary values obtained in this analysis are useful for economic analysis and health services planning and may have some limited value for clinical prognosis. DE Acquired Immunodeficiency Syndrome/CLASSIFICATION/DIAGNOSIS/ *IMMUNOLOGY Cohort Studies Computer Simulation Human HIV Infections/CLASSIFICATION/DIAGNOSIS/*IMMUNOLOGY *Leukocyte Count Models, Statistical T4 Lymphocytes/*IMMUNOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).